Trade receivables segment

Faced with strong demand and armed with a decade of experience in this segment, Credi Impresa Futuro aims to foster the growth of trade finance loans to Italian SMEs. Credi Impresa Futuro's target companies are SMEs in the small segment that are not benefiting from the liquidity available on the market: this allows Banca IFIS to take a strong position in this segment, so as to pursue growth targets in terms of the number of customers and loans. Multichannel service, real-time continuous support, a constantly expanding team of professionals that ensures an open and constant dialogue with clients, and the physical presence through our network of sales account managers—these are the strengths of Credi Impresa Futuro. The web—in all its forms—is the preferred method to contact customers, giving more and more opportunities for raising financing to businesses requiring it. The brand's website is

Banca IFIS International is one of the most active players in international factoring. It stands out from the competition due to its direct presence in foreign markets, such as Poland (with the subsidiary IFIS Finance), Romania, Hungary, and India. In addition, there is a unit based in Milan dedicated to international growth. The goal of international operations is developing exports by promoting relations with companies more oriented to international markets, which are considered to be more stable and have greater growth potential compared to businesses more focused on the domestic market. With its ability to act not only as a reference in providing financing to businesses, but also as a consultant to those customers who intend to enter new markets, Banca IFIS International effectively supports companies in seizing growth opportunities.

Banca IFIS Pharma specialises in creating integrated management solutions for companies in the healthcare, pharmaceutical, diagnostic and service sectors wishing to factor receivables due from Italy's National Health Service. Since 1 July 2015, the Pharma Area includes the new “Pharmacies” business unit, which offers pharmacy owners a comprehensive and reliable package of solutions meeting all their financial needs. The purpose of this new business unit is establishing itself as a more structured player adept at supporting working capital. In particular, medium-long term loans can help pharmacies deal with their stock of debts—the result of the sudden tightening of the terms and conditions imposed by their suppliers seen in the last few years. This has generated a stock of past due exposures that hinders their ability to negotiate more favourable terms and conditions, and therefore to manage working capital more freely. The website of these two units is